The Value of Access: Modelling Outcomes for New Blood Cancer Therapies
This report examines how pre-existing healthcare challenges and the pandemic affected blood cancer patients’ care, plus how overcoming the barriers to care could benefit patients and society.
What were the pandemic’s cancer care service impacts, both direct and indirect, on patients? What are the major barriers to accessing therapies, and what can be done to remove the barriers? How would patients and Canada’s economy benefit from improving access to new therapies?
Read the online experience to get our full analysis.
Cette publication est disponible en français.
There are no reviews yet.